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down-regulating the expressions of IL-10 and TGF-b, anti-
inﬂammatory cytokine, and promoting the IL-12 expression,
pro-inﬂammatory cytokine. With HBV subunit vaccine, CIM
can also enhance antigen speciﬁc cell-mediated response in
animals.
The combination of LMS and CIM can synergistically enhance
the immunogenicity of HBV subunit vaccine and leads to a
robust at a comparative level achieved with CpG+alum in
animals. Since the safety proﬁle of the two chemicals, their
combination with the HBV subunit vaccine may provide a
cost effective and safe, yet effective therapy to treat those
individuals chronically infected by HBV.
Concurrent Session 13 Viral Hepatitis and
Hepatocellular Carcinoma
I-64 Viral factors of hepatocellular carcinoma in chronic
hepatitis B
H.L.Y. Chan*. The Chinese University of Hong Kong, China
Chronic hepatitis B is the commonest cause of
hepatocellular carcinoma (HCC) in Asia. Various clinical
factors including older age, male gender, positive HBeAg
and liver cirrhosis have been suggested to associate with
a higher risk of HCC. Higher HBVDNA has been shown by
various longitudinal studies to associate with a higher risk of
liver cirrhosis and HCC. We have performed a longitudinal
study comparing the serial HBVDNA among patients who
developed and did not develop HCC. The trough HBVDNA
level seemed to be the most important determinant of HCC
development.
We have performed a prospective longitudinal study among
426 chronic hepatitis B patients with a follow-up up to
5 years. Genotype C HBV is found to be an independent risk
factor of HCC over genotype B HBV. This is probably related
to the more active liver disease and higher proportion of
basal core promoter mutations related to genotype C HBV.
In another study including 1006 patients followed up for
over 7 years, HBV subgenotype Ce was found to associate
with highest risk of HCC independent of HBVDNA levels.
To further investigate the virological mechanism of HCC by
different HBV genotypes/subgenotypes, we have performed
full genome sequencing of the HBV in 100 chronic hepatitis B
patients with HCC and another 100 patients without
HCC. Different viral genotypes and subgenotypes have
different viral genomic markers for HCC. After data mining,
algorithms can be derived with a sensitivity of HCC
prediction of 70% 80%.
I-65 Hepatitis B and C viral cellular interactions in the
pathogenesis of hepatocellular carcinoma
J.R. Wands*. The Liver Research Center, Rhode Island
Hospital and the Warren Alpert Medical School of Brown
University, Providence, Rhode Island, USA
On a global scale, chronic hepatitis B virus (HBV) and
hepatitis C virus (HCV) account for well over 90% of
hepatocellular carcinoma (HCC). Our Liver Research Center
has been interested in viral-cellular protein interactions
that may be responsible for this exceedingly high risk of
hepatocyte transformation during persistent viral infection
and how anti-viral agents may reduce this risk. There
are two major signal transduction pathways that appear
to be activated in most HCC and may occur very early
in the disease process such as in dysplastic hepatocytes.
The ﬁrst is the insulin/IGF-1/IRS-1 signal transduction
pathway involved in hepatocyte growth and survival. The
other major signaling pathway involves the Wnt/Frizzled/b-
catenin cascade involved in cell migration and proliferation
normally “on” during embryonic development. However,
aberrant activation of this pathway in adults can lead to
tumor formation through its stimulatory effects on cell
migration, invasion, and cell proliferation.
Finally, we will discuss recent reports that demonstrate
interactions of HCV and HBV structural and non-structural
proteins on various components of these two pathways that
tend to promote activation during chronic viral infection.
A further understanding of the interaction of viral and
hepatocyte-derived cellular proteins will provide insights
into the molecular mechanisms of HBV and HCV related HCC
and begin to deﬁne the critical role of these interactions in
the transformation process. These studies describe essential
molecular mechanisms that may serve as targets for
possible therapeutic intervention in addition to approaches
that reduce viral replication and persistence via anti-viral
agents.
I-66 How to predict HCC development in patients with
chronic hepatitis B viral infection?
K.H. Han*. Department of Internal Medicine and Liver
Cirrhosis Clinical Research Center, , Yonsei University
College of Medicine, Seoul, Korea
Hepatocellular carcinoma (HCC) is one of the major
malignant diseases in Asia. The incidence rates of HCC
geographically differ according to high prevalence of
hepatitis B virus (HBV) infection.
Chronic necro-inﬂammation by persistent HBV infection can
progress to cirrhosis and meanwhile genetic changes can
lead to the occurrence of HCC. Long standing inﬂammatory
activities may play an important role in the clinical course
of HBV infection. We studied 188 patients with chronic
hepatitis B for a mean of 80.6 months to evaluate the long-
term outcome of chronic hepatitis B patients, based on the
histological grade and stage, in Korea. The development of
cirrhosis correlated well with the grade of porto-periportal
activity and stage of ﬁbrosis (p < 0.05). Patients with a higher
grade of porto-periportal activity and higher stage of ﬁbrosis
had a greater chance of developing cirrhosis. Based on ALT
levels during follow-up, we classiﬁed the patients into active
and inactive biochemical hepatitis groups. The probabilities
of developing cirrhosis, decompensation, and HCC were
signiﬁcantly higher in the active biochemical hepatitis group
(p < 0.01). Multivariate analysis showed that the prognostic
factors for developing cirrhosis and decompensation were
age and biochemical hepatitis activity during follow-up.
From our follow-up study, we can conclude that
development of cirrhosis correlated well with the grade
of porto-periportal activity and stage of ﬁbrosis at liver
biopsy. In addition, biochemical hepatitis activity during the
follow-up was an independent prognostic factor affecting
the long-term outcome of chronic hepatitis B. Therefore,
effective control of hepatitis activity might improve the
long-term outcome of chronic hepatitis B patients.
In high endemic areas of chronic HBV infection, a screening
program to detect HCC development conﬁned to the
patients with chronic B viral liver disease is necessitated.
The cost-effectiveness of a screening program could
probably be increased further by focusing the screening
of patients according to the risk factors most likely to
affect them. Therefore, it is very important to assess the
risk factors of HCC development. We demonstrated that
the more risk factors, the higher HCC development. A
tailored screening system with individual prediction model
for HCC was also proposed based on relative signiﬁcance
of risk factors and prospectively conﬁrmed. Recent our
study of 688 patients with chronic B viral liver diseases
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without cirrhosis revealed signiﬁcant risk factors for HCC as
follows: age (over 40 yrs old, p = 0.009), male (p = 0.011),
AFP (>20 ng/mL, p = 0.011), severe liver parenchymal echo-
pattern in ultrasonography (p = 0.0002) and heavy alcoholics
(p = 0.0428). Based on these factors, the establishment of
screening program for HCC is in the pipeline.
Concurrent Session 14 Fungal Infection
I-67 Fungal infections Insights from the bench-side
M. Hui *. Department of Microbiology, The Chinese
University of Hong Kong, The Prince of Wales Hospital,
Shatin, Hong Kong SAR, China
Invasive fungal infections have always been a life-
threatening disease for immunocompromised patients.
Traditionally, the microbiology laboratory often offers
little help in the diagnosis and treatment of these
patients. However, with the advent of molecular and
chemical diagnostic methods, and the standardization of
susceptibility testing, more insights can now be sheded.
Molecular techniques generally detect the presence of
the highly conserved region of the fungal organisms. Its
success has been variable, and standardization of methods
has been slow in progress. Chemical detection methods
such as mannan, galactomannan has received renewed
interest. The application of beta-D-glucan detection in the
clinical settings has raised further enthusiasm not only in
its high sensitivity, but also potentially as a monitoring
marker for disease progress and treatment response. Disc
diffusion susceptibility testing has allowed certain azole
agents to be readily tested in the laboratory. Although the
susceptibility of most Candida species can be predicted from
its speciation, the availability of susceptibility surveillance
programme allows monitoring of resistance pattern. The
advent of echinocandins further improves the clinical
outcomes. Its selective toxicity is a much needed contribute
in the treatment of these fatal diseases. With further
clinical trials and animal models, understanding of this class
of anti-fungal agent should widen its clinical application.
I-68 Invasive fungal infections in Asia-Paciﬁc region
P.R. Hsueh*. Divisions of Clinical Microbiology and
Infectious Diseases, Departments of, Laboratory Medicine
and Internal Medicine, National Taiwan University Hospital,
, National Taiwan University College of Medicine, Taipei,
Taiwan
Invasive fungal infection has emerged as an important
nosocomial infection, especially in critically ill patients.
An increasing incidence of candidemia became apparent
from the 1980 to the end of the 1990’s followed by relative
stability. The incidence of candidemia in intensive care
units (ICUs) is 5 to 10-fold that in overall hospitals, and
more than 100-fold greater than in the general population
in Asia-Paciﬁc region. The crude mortality rate of patients
with candidemia is in the range of 35 60%, however,
ICU patients with candidemia had a higher mortality rate
than non-ICU patients. The crude mortality with invasive
aspergillosis is more than 60%, particularly in patients
with hematological malignancy and transplant patients.
Candida albicans remains the predominant cause of invasive
candidiasis in more than 50% of all cases. C. tropicalis,
C. glabrata and C. parapsilosis are the three most common
non-albicans Candida species causing invasive candidiasis.
The above four Candida species account for more than
90% of invasive candidiasis. Overall, invasive non-albicans
Candida isolates remained highly susceptible to ﬂuconazole
(>90% susceptible) over the past two decades. However, the
susceptible rate of C. glabrata to ﬂuconazole varied widely
from 22 to 72% and the resistant rate ranged from 2 to 16% in
Asian countries. Analysis of the ﬂuconazole susceptibilities
of 204 bloodstream C. glabrata isolates revealed a rapid
shift from susceptible (64% in 1999 to 2001 to 19% in 2007)
to susceptible-dose dependent (27% in 1999 to 2001 and
75% in 2007) in Taiwan. Periodic surveillance is needed to
monitor antifungal resistance because reduced ﬂuconazole
susceptibility in non-albicans Candida is not an uncommon
trend. Echinocandins continue to exhibit excellent in vitro
fungicidal activities against all Candida isolates and are
promising agents for the treatment of patients with invasive
candidiasis, particularly in ICU patients.
I-69 Genotype distribution of Candida albicans in
China
F.Y. Bai1 *, J. Li1, S.R. Fan2, D.M. Li3. 1Institute of
Microbiology, Chinese Academy of Sciences, Beijing 100101,
China, 2Department of Obstetrics and Gynecology, Peking
University Shenzhen Hospital, Shenzhen, Guangdong
518036, China, 3Department of Dermatology, Peking
University Third Hospital, Beijing 100083, China
Candida albicans is the most common opportunistic fungal
pathogen of humans. It causes from benign infections such
as oral and vaginal candidiasis to fatal, systematic infections
in immunocompromised or critically ill patients. The
genotype distributions of C. albicans strains with different
sources were investigated using single-strand conformation
polymorphism and GeneScan analyses of a microsatellite
locus called CAI. The C. albicans strains from various
extragenital sites, those from vaginas of asymptomatic
women, and those causing vulvovaginal candidosis (VVC) of
women and balanoposthitis of men, were employed. Genetic
similarity of representative strains with the same and
different CAI genotypes were examined by sequence analysis
of housekeeping genes CaADP1, CaSYA1 and CaVPS13.
The CAI genotypes of independent C. albicans strains from
extragenital sites were mostly of individual speciﬁcity.
In contrast, strains associated with VVC were mainly
concentrated to a few dominant genotypes, with two CAI
genotypes being the most common. The enrichment trend
of the dominant genotypes of C. albicans strains correlated
positively with the severity of VVC. A similar biased genotype
distribution pattern of C. albicans strains associated with
balanoposthitis was also revealed. The genetic similarity of
strains with the dominant genotypes associated with both
VVC and balanoposthitis was conﬁrmed by sequence analysis
of the three genes. The results suggest the existence of
vaginopathic C. albicans strains with enhanced virulence
and tropism for the vagina, and the high possibility of sexual
transmission of genital C. albicans infection. Identiﬁcation
of speciﬁc genotypes that correlate with severity of VVC is
certainly of diagnostic and therapeutic signiﬁcance.
I-70 Non-culture diagnosis of fungal infection
R.Y. Li *. Peking University First Hospital and Research
Center for Medical Mycology, Beijing, China
In recent years, as the growing number of immunocompro-
mised hosts, there is an obviously increasing of opportunistic
fungal infections. Candida infection is the commonest one
especially Candidemia could lead to a high mortality.
Other non-Candida yeasts infections are emerging, such
as Trichosporon spp. infection. In BMT patients and other
immunocompromised patients, invasive aspergillosis has
been one of the major causes of death. How to improve
the early and speciﬁc diagnosis level of fungal infection,
especially the invasive fungal infection, is a big challenge
